TY - JOUR
T1 - Recent advances in myocardial contrast echocardiography
AU - Gunda, Madhavi
AU - Mulvagh, Sharon L.
PY - 2001
Y1 - 2001
N2 - Myocardial contrast echocardiography (MCE) has undergone many advances in the past several years through remarkable developments in contrast agent and ultrasound equipment technology. Microbubble ultrasound contrast agents can now safely transit the pulmonary circulation to provide opacification of the left ventricular cavity, improved endocardial border definition, and detection of myocardial perfusion. The role of contrast echocardiography in enhancing technically difficult images is now well established in clinical practice, and has proven especially useful in the stress and intensive care unit settings. Major progress has been made in the application of MCE for myocardial perfusion assessment in acute and chronic ischemic heart disease syndromes, and comprises the focus of this review. Advances in novel applications of contrast echocardiography, including targeted delivery of genetic and pharmaceutical materials, have also occurred, but remain in a preclinical phase. In summary, the combination of recent innovations in ultrasound equipment, and microbubble acoustics, allows for exciting exploration of the expanding role of contrast echocardiography in clinical practice.
AB - Myocardial contrast echocardiography (MCE) has undergone many advances in the past several years through remarkable developments in contrast agent and ultrasound equipment technology. Microbubble ultrasound contrast agents can now safely transit the pulmonary circulation to provide opacification of the left ventricular cavity, improved endocardial border definition, and detection of myocardial perfusion. The role of contrast echocardiography in enhancing technically difficult images is now well established in clinical practice, and has proven especially useful in the stress and intensive care unit settings. Major progress has been made in the application of MCE for myocardial perfusion assessment in acute and chronic ischemic heart disease syndromes, and comprises the focus of this review. Advances in novel applications of contrast echocardiography, including targeted delivery of genetic and pharmaceutical materials, have also occurred, but remain in a preclinical phase. In summary, the combination of recent innovations in ultrasound equipment, and microbubble acoustics, allows for exciting exploration of the expanding role of contrast echocardiography in clinical practice.
UR - http://www.scopus.com/inward/record.url?scp=0034887517&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034887517&partnerID=8YFLogxK
U2 - 10.1097/00001573-200107000-00003
DO - 10.1097/00001573-200107000-00003
M3 - Review article
C2 - 11574784
AN - SCOPUS:0034887517
SN - 0268-4705
VL - 16
SP - 231
EP - 239
JO - Current opinion in cardiology
JF - Current opinion in cardiology
IS - 4
ER -